Publications 2020

2020

A Phase 3 Trial of Luspatercept in Patients With Transfusion-Dependent β-Thalassemia.

Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ et al. (2020)  

New England Journal of Medicine 382 (13), 1219-1231

2020

SUCCESSFUL KIDNEY TRANSPLANTATION IN A PATIENT WITH STABLE MULTIPLE MYELOMA.

Lai C, Ying T, Ho PJ, Wyburn K, Gallagher M, Chadban S (2020)

Intern Med J. 50(4):492-494. doi: 10.1111/imj.14790.

2020

PATIENT-REPORTED OUTCOME MEASURES IN MULTIPLE MYELOMA: REAL-TIME REPORTING TO IMPROVE CARE (MY-PROMPT) - A PILOT RANDOMIZED CONTROLLED TRIAL.

Moore EM, King TA, Wood EM, Ruseckaite R, Klarica D, Spencer A, Ho PJ, Quach H, Prince HM, McQuilten ZK.

Am J Hematol (2020) 95:E178-181. doi: 10.1002/ajh.25815.